A detailed history of Raymond James & Associates transactions in Encompass Health Corp stock. As of the latest transaction made, Raymond James & Associates holds 124,937 shares of EHC stock, worth $10.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
124,937
Previous 137,476 9.12%
Holding current value
$10.7 Million
Previous $9.17 Million 12.48%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$66.88 - $82.58 $838,608 - $1.04 Million
-12,539 Reduced 9.12%
124,937 $10.3 Million
Q4 2023

Jan 16, 2024

SELL
$60.63 - $67.55 $1.66 Million - $1.85 Million
-27,460 Reduced 16.65%
137,476 $9.17 Million
Q3 2023

Oct 24, 2023

BUY
$65.21 - $71.81 $583,759 - $642,843
8,952 Added 5.74%
164,936 $11.1 Million
Q2 2023

Jul 25, 2023

SELL
$54.1 - $67.71 $1.4 Million - $1.75 Million
-25,792 Reduced 14.19%
155,984 $10.6 Million
Q1 2023

Apr 14, 2023

BUY
$51.55 - $63.21 $2.08 Million - $2.54 Million
40,254 Added 28.44%
181,776 $9.83 Million
Q4 2022

Feb 08, 2023

SELL
$47.0 - $59.82 $143,256 - $182,331
-3,048 Reduced 2.11%
141,522 $8.47 Million
Q3 2022

Oct 25, 2022

BUY
$45.23 - $53.86 $426,473 - $507,845
9,429 Added 6.98%
144,570 $6.54 Million
Q2 2022

Aug 12, 2022

SELL
$42.94 - $59.09 $239,819 - $330,017
-5,585 Reduced 3.97%
135,141 $7.58 Million
Q1 2022

May 11, 2022

BUY
$47.33 - $56.71 $2.19 Million - $2.62 Million
46,173 Added 48.83%
140,726 $10 Million
Q4 2021

Feb 08, 2022

BUY
$45.03 - $58.77 $2.15 Million - $2.81 Million
47,772 Added 102.12%
94,553 $6.17 Million
Q3 2021

Nov 02, 2021

BUY
$59.25 - $66.95 $1.23 Million - $1.39 Million
20,720 Added 79.51%
46,781 $3.51 Million
Q2 2021

Aug 11, 2021

BUY
$62.08 - $70.52 $101,066 - $114,806
1,628 Added 6.66%
26,061 $2.03 Million
Q1 2021

May 14, 2021

BUY
$62.07 - $69.61 $1,675 - $1,879
27 Added 0.11%
24,433 $2 Million
Q4 2020

Feb 12, 2021

SELL
$48.77 - $68.38 $27,945 - $39,181
-573 Reduced 2.29%
24,406 $2.02 Million
Q3 2020

Nov 04, 2020

BUY
$47.96 - $55.47 $200,664 - $232,086
4,184 Added 20.12%
24,979 $1.62 Million
Q2 2020

Jul 28, 2020

SELL
$47.18 - $59.64 $30,525 - $38,587
-647 Reduced 3.02%
20,795 $1.29 Million
Q1 2020

Apr 21, 2020

SELL
$39.83 - $65.88 $435,541 - $720,397
-10,935 Reduced 33.77%
21,442 $1.37 Million
Q4 2019

Feb 12, 2020

SELL
$48.29 - $57.35 $18,301 - $21,735
-379 Reduced 1.16%
32,377 $2.24 Million
Q3 2019

Nov 07, 2019

SELL
$46.54 - $53.72 $249,640 - $288,154
-5,364 Reduced 14.07%
32,756 $2.07 Million
Q2 2019

Aug 06, 2019

SELL
$45.91 - $52.15 $1.86 Million - $2.12 Million
-40,584 Reduced 51.57%
38,120 $2.42 Million
Q1 2019

May 06, 2019

SELL
$46.46 - $54.42 $741,501 - $868,543
-15,960 Reduced 16.86%
78,704 $4.6 Million
Q4 2018

Feb 11, 2019

BUY
$47.37 - $62.44 $418,229 - $551,282
8,829 Added 10.29%
94,664 $5.84 Million
Q3 2018

Nov 14, 2018

BUY
$54.18 - $65.51 $1.69 Million - $2.04 Million
31,117 Added 56.87%
85,835 $6.69 Million
Q2 2018

Aug 14, 2018

SELL
$44.3 - $55.08 $84,923 - $105,588
-1,917 Reduced 3.38%
54,718 $3.71 Million
Q1 2018

May 14, 2018

BUY
$39.51 - $46.6 $2.24 Million - $2.64 Million
56,635 New
56,635 $3.24 Million

Others Institutions Holding EHC

About Encompass Health Corp


  • Ticker EHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 99,777,600
  • Market Cap $8.56B
  • Description
  • Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients w...
More about EHC
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.